午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

methyl {[3-(2-methyl-2-propenyl)-4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetate

methyl {[3-(2-methyl-2-propenyl)-4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetate Struktur
330179-88-9
CAS-Nr.
330179-88-9
Englisch Name:
methyl {[3-(2-methyl-2-propenyl)-4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetate
Synonyma:
methyl {[3-(2-methyl-2-propenyl)-4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetate;Acetic acid, 2-[[3,5,6,7-tetrahydro-3-(2-methyl-2-propen-1-yl)-4-oxo-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]thio]-, methyl ester
CBNumber:
CB51906467
Summenformel:
C16H18N2O3S2
Molgewicht:
350.46
MOL-Datei:
330179-88-9.mol

methyl {[3-(2-methyl-2-propenyl)-4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetate Eigenschaften

Sicherheit

methyl {[3-(2-methyl-2-propenyl)-4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetate Chemische Eigenschaften,Einsatz,Produktion Methoden

methyl {[3-(2-methyl-2-propenyl)-4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

methyl {[3-(2-methyl-2-propenyl)-4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6176 60
Specs --
 info@specs.net The Netherlands 6833 70
  • methyl {[3-(2-methyl-2-propenyl)-4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetate
  • Acetic acid, 2-[[3,5,6,7-tetrahydro-3-(2-methyl-2-propen-1-yl)-4-oxo-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl]thio]-, methyl ester
  • 330179-88-9
Copyright 2019 ? ChemicalBook. All rights reserved